About us
Services & Solutions
Chemistry DMPK Discovery Biology Oncology Pharmacology Biologics
Medicinal Chemistry Peptide Chemistry Computational Chemistry Synthetic Chemistry Analytical Chemistry Scale Up Chemistry
In Vivo PK and TK In Vitro ADME Bioanalytical Service Exploratory Toxicity In Rodents, Dogs and Monkeys Large Molecules Capabilities Bioanalytical Instruments
Biochemical Assays Cellular Assays Protein Science Assay Technologies Biophysics SPR Safety Pharmacology Screening Services Key Instruments
PDX CDX Orthotopic Models Syngeneic Models Humanized Mouse Models CAR-T and CAR-NK Mouse Models In Vitro Assays
Immunology Inflammation Metabolic NASH/MASH Respiratory Neuroscience
Systematic Antibody Discovery Service
Process R&D Scale Up Synthesis DS Manufacturing
Flow Chemistry Sugar Chemistry Peptide Chemistry Preparative Purification Capacity Process Safety Assessment
Synthetic and Scale Up Chemistry Parallel Synthesis
Flow Chemistry Kilo and Pilot Scale Production RSM and Intermediates Manufacturing QA EHS
Pre-Formulation Formulation, Analytical and Process Development Drug Product Manufacturing
Bioavailability Enhancement Modified Release
Commercial Manufacturing
Platforms
News & Resources
Careers
Contact us
CN EN
×

news

Company News Events Insights Webinars Virtual Tours

BioDuro Launches as Unique Contract Research and Drug Manufacturing Organization

CRO offering integrated drug discovery, API synthesis, formulation, and cGMP manufacturing services in Oncology, Inflammatory Disease, Metabolism, and CNS.
June 06, 2016

BioAtla Enters Into Strategic License And Option Agreement With Pfizer For A New Class Of Antibody Therapeutics

BioAtla Enters Into Strategic License And Option Agreement With Pfizer For A New Class Of Antibody Therapeutics | BioDuro-Sundia | Moving You Forward
December 07, 2015

BioDuro, LLC Adds Industry Veteran CFO to Executive Team

BioDuro, LLC appoints industry veteran Ian R Wisenberg as Chief Financial Officer, leveraging his extensive biotech and China business expertise.
November 18, 2015

BioDuro, LLC Announces Merger with Formex, LLC, and New Leadership

PRNewswire – BioDuro, a global leader in CRO services, merges with Formex, enhancing API formulation and cGMP manufacturing capabilities under new leadership
November 11, 2015

Integrating Drug Discovery and Development to Improve Efficiency and Candidate Success

Considering the increasing pressures on the industry to reduce clinical time and cost, it is clear the industry must find ways to improve these dismal success..
October 21, 2015
Total 85 12...91011121314151617
Subscribe to BioDuro-Sundia
Receive our newsletter and information on upcoming events
Your trusted partner from drug discovery and
development to commercialization

Home

About us

Services & Solutions

Platforms

News & Resources

Careers

Contact us

Explore

Discovery

Drug Substance

Drug Product

© 2023 BioDuro-Sundia. All rights reserved
Terms of Use Privacy Policy
We use necessary cookies to ensure our website functions properly and to keep it secure. These necessary cookies must be enabled. By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. You can personalize or withdraw your consent at any moment by clicking on the link "Cookies Settings". For more information on how we use cookies, including the total lifespan of cookies and the identity of third parties intervening on our website, please consult the Privacy Notice available in the site footer.
Accept all